Section 1134,
Pub. L. 92–255, title II, §224, Mar. 21, 1972, 86 Stat. 71
, provided for establishment of research and development programs by Director.
Section 1135,
Pub. L. 92–255, title II, §225, Mar. 21, 1972, 86 Stat. 72
, provided for establishment of a single non-Federal share requirement.
Section 1136,
Pub. L. 92–255, title II, §226, Mar. 21, 1972, 86 Stat. 72
, provided for Director to make drug prevention function recommendations to President and to consult with responsible agencies with respect to drug prevention functions.
Section 1137,
Pub. L. 92–255, title II, §227, Mar. 21, 1972, 86 Stat. 72
, provided for resolution of agency conflicts with regard to drug prevention functions.
Section 1138,
Pub. L. 92–255, title II, §228, Mar. 21, 1972, 86 Stat. 72
, provided for communications and liaison with respect to drug prevention functions by one of Assistant Directors.
Section 1139,
Pub. L. 92–255, title II, §229, Mar. 21, 1972, 86 Stat. 72
, provided, with respect to drug prevention functions, coordination of State and local governments, availability of information and other services and activities.
Section 1140,
Pub. L. 92–255, title II, §230, Mar. 21, 1972, 86 Stat. 73
, provided for a management oversight review by a Federal officer.
Section 1141,
Pub. L. 92–255, title II, §231, Mar. 21, 1972, 86 Stat. 73
, provided for convening of a council of officials of Federal agencies responsible for drug prevention functions by Director.
Section 1142,
Pub. L. 92–255, title II, §232, Mar. 21, 1972, 86 Stat. 73
, provided for designation of the Director to represent Government in international negotiations related to drug prevention functions.
Section 1143,
Pub. L. 92–255, title II, §233, Mar. 21, 1972, 86 Stat. 73
, provided for an annual written report to the President by the Director.
Statutory Notes and Related Subsidiaries
Effective Date of Repeal
Section 1104 of this title, prior to repeal by
Pub. L. 94–237, §4(c)(1), Mar. 19, 1976, 90 Stat. 244
, provided for repeal of sections effective June 30, 1975.